Abstract
Tumorigenesis is a multi-step process due to an accumulation of genetic mutations in multiple genes in diverse pathways which ultimately lead to loss of control over cell growth. It is well known that inheritance of rare germline mutations in genes involved in tumorigenesis pathways confer high lifetime risk of neoplasia in affected individuals. Furthermore, a substantial number of multiple malformation syndromes include cancer susceptibility in their phenotype. Studies of the mechanisms underlying these inherited syndromes have added to the understanding of both normal development and the pathophysiology of carcinogenesis. Myotonic dystrophy (DM) represents a group of autosomal dominant, multisystemic diseases that share the clinical features of myotonia, muscle weakness, and early-onset cataracts. Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) result from unstable nucleotide repeat expansions in their respective genes. There have been multiple reports of tumors in individuals with DM, most commonly benign calcifying cutaneous tumors known as pilomatricomas. We provide a summary of the tumors reported in DM and a hypothesis for a possible mechanism of tumorigenesis. We hope to stimulate further study into the potential role of DM genes in tumorigenesis, and help define DM pathogenesis, and facilitate developing novel treatment modalities.
Similar content being viewed by others
References
Harper PS (2001) Myotonic dystrophy. WB Saunders, London
The International Myotonic Dystrophy Consortium (IDMC) (2000) New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 54:1218–1221
Osanai R, Kinoshita M, Hirose K, Homma T, Kawabata I (2000) CTG triplet repeat expansion in a laryngeal carcinoma from a patient with myotonic dystrophy. Muscle Nerve 23:804–806
Ogata K, Takahashi A, Oguchi N, Ishitoya J, Fuse S, Shimpo T (1998) Somatic mosaicism of p(CTG)n expansion in a case of myotonic dystrophy with parotid tumor. Rinsho Shinkeigaku 38:736–738
Kinoshita M, Igarashi A, Komori T et al (1997) Differences in CTG triplet repeat expansions in an ovarian cancer and cyst from a patient with myotonic dystrophy. Muscle Nerve 20:622–624
Jinnai K, Sugio T, Mitani M, Hashimoto K, Takahashi K (1999) Elongation of (CTG)n repeats in myotonic dystrophy protein kinase gene in tumors associated with myotonic dystrophy patients. Muscle Nerve 22:1271–1274
Banuls J, Botella R, Palau F et al (2004) Tissue and tumor mosaicism of the myotonin protein kinase gene trinucleotide repeat in a patient with multiple basal cell carcinomas associated with myotonic dystrophy. J Am Acad Dermatol 50:S1–S3
Moxley RTIII (1994) Potential for growth factor treatment of muscle disease. Curr Opin Neurol 7:427–434
Vlachopapadopoulou E, Zachwieja JJ, Gertner JM et al (1995) Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy—a clinical research center study. J Clin Endocrinol Metab 80:3715–3723
Kaaks R (2004) Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262:247–260 Discussion 260–268
Marrogi AJ, Dehner LP, Coffin C, Wick MR (1992) Pilomatrical neoplasms in children and young adults. Am J Dermatopath 14:87–94
Moehlenbeck FW (1973) Pilomatricoma (calcifying epithelioma). A statistical study. Arch Dermatol 108:532–534
Julian CG, Bowers PW (1998) A clinical review of 209 pilomatricomas. J Am Acad Dermatol 39:191–195
Masuno M, Imaizumi K, Ishii T, Kuroki Y, Baba N, Tanaka Y (1998) Pilomatricomas in Rubinstein-Taybi syndrome. Am J Med Genet 77:81–82
Pujol RM, Casanova JM, Egido R, Pujol J, de Moragas JM (1995) Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome? Pediatr Dermatol 12:331–335
Hills RJ, Ive FA (1992) Familial multiple pilomatricomas. Br J Dermatol 127:194–195
Cantwell AR Jr, Reed WB (1965) Myotonia atrophica and multiple calcifying epithelioma of Malherbe. Acta Derm Venereol 45:387–390
White GM (1992) Multiple pilomatricomas of the scalp. Int J Dermatol 31:348–350
Urvoy M, Legall F, Toulemont PJ, Chevrant-Breton J (1996) Multiple pilomatricoma. Apropos of a case. J Fr Ophtalmol 19:464–466
Street ML, Rogers RSIII (1991) Multiple pilomatricomas and myotonic dystrophy. J Dermatol Surg Oncol 17:728–730
Schwartz BK, Peraza JE (1987) Pilomatricomas associated with myotonic dystrophy. J Am Acad Dermatol 16:887–888
Salerni E, Bonatti ML, D’Aurizio C, Baldassarre M, D’Alessandro E, Prencipe M (1988) Multiple pilomatricomas and myotonic dystrophy: a case report. Riv Neurol 58:124–126
Runne U, Chilf GN, Zentner J (1982) Multiple pilomatricomas as symptoms of Curschmann-Steinert myotonia dystrophica. Hautarzt 33:271–275
Ribera M, Calderon P, Barranco C, Ferrandiz C (1989) Multiple pilomatricomas associated with myotonic dystrophy and medullary carcinoma of the thyroid. Med Cutan Ibero Lat Am 17:395–398
Nishie W, Iitoyo M, Miyazawa H (2001) Follicular cyst in a patient with myotonic dystrophy: a case of cyst with differentiation toward follicular infundibulum, isthmus, inner root sheath, and hair. Am J Dermatopathol 23:521–524
Martinez-Albaladejo M, Alguacil-Garcia G, de Paco-Moya M, Moreno-Requena J (1995) Dystrophia myotonica with multiple pilomatricomas. Rev Clin Esp 195:516–517
Laredo Ortiz C, Munoz Romero F, Mallent Anon J, Domenech Miro E, Tafalla Pena M (1997) Multiple pilomatricomas associated with Steinert disease. An Med Interna 14:409–411
Kopeloff I, Orlow SJ, Sanchez MR (1992) Multiple pilomatricomas: report of two cases and review of the association with myotonic dystrophy. Cutis 50:290–292
Harper PS (1972) Calcifying epithelioma of Malherbe. Association with myotonic muscular dystrophy. Arch Dermatol 106:41–44
Harper PS (1971) Calcifying epithelioma of Malherbe and myotonic dystrophy in sisters. Birth Defects Orig Artic Ser 7:343–345
Graells J, Servitje O, Badell A, Notario J, Peyri J (1996) Multiple familial pilomatricomas associated with myotonic dystrophy. Int J Dermatol 35:732–733
Geh JL, Moss AL (1999) Multiple pilomatricomata and myotonic dystrophy: a familial association. Br J Plast Surg 52:143–145
Filla A, Perretti A, Barbieri F et al (1982) Myotonic dystrophy and pilomatricomas: an unusual association. Acta Neurol (Napoli) 4:79–91
Farrell AM, Ross JS, Barton SE, Bunker CB (1995) Multiple pilomatricomas and myotonic dystrophy in a patient with AIDS. Clin Exp Dermatol 20:423–424
Draper MR, Pickles JM (2000) Pleomorphic adenoma and myotonic dystrophy: an association? J Laryngol Otol 114:985–987
Delfino M, Monfrecola G, Ayala F, Suppa F, Piccirillo A (1985) Multiple familial pilomatricomas: a cutaneous marker for myotonic dystrophy. Dermatologica 170:128–132
Chiaramonti A, Gilgor RS (1978) Pilomatricomas associated with myotonic dystrophy. Arch Dermatol 114:1363–1365
Bouadjar B, Masmoudi AN, Bouhadef A, Ysmail-Dahlouk M (1992) Multiple pilomatricoma and myotonic dystrophy. Ann Dermatol Venereol 119:899–900
Betlloch I, Morell A, Silvestre JF, Sevila A, Banuls J, Alfonso R (1997) Pilomatricoma and myotonic dystrophy. Letter. Rev Neurol 25:306–307
Barberio E, Nino M, Dente V, Delfino M (2002) Guess what! Multiple pilomatricomas and Steiner disease. Eur J Dermatol 12:293–294
Aso M, Shimao S, Takahashi K (1981) Pilomatricomas: association with myotonic dystrophy. Dermatologica 162:197–202
Berberian BJ, Colonna TM, Battaglia M, Sulica VI (1997) Multiple pilomatricomas in association with myotonic dystrophy and a family history of melanoma. J Am Acad Dermatol 37:268–269
Varras M, Polyzos D, Alexopoulos C, Pappa P, Akrivis C (2003) Torsion of a non-gravid leiomyomatous uterus in a patient with myotonic dystrophy complaining of acute urinary retention: anaesthetic management for total abdominal hysterectomy. Clin Exp Obstet Gynecol 30:147–150
Vandecaveye V, Verswijvel G, Colla P, Verhelst H, VanRobaeys J, Palmers Y (2003) Cystic insulinoma of the pancreas in a patient with myotonic dystrophy: correlation of imaging and pathologic findings. Jbr-Btr 86:268–271
Suzuki H, Aoyagi M (2003) Anesthetic management with a laryngeal mask airway for gastrectomy in a patient with myotonic dystrophy. Masui 52:993–995
Sugio T, Jinnai K, Ohara T et al (1999) Myotonic dystrophy associated with insulinoma. Intern Med 38:504–506
Stieler W, Plewig G (1986) Multiple basaliomas in Curschmann-Steinert myotonia atrophica. Hautarzt 37:226–229
Saponaro AE, Marini MA, Rossi GC, Casas JG (2006) Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1. Int J Dermatol 45:87–88
Rosenberg NL, Diliberti JH, Andrews AM, Buist NR (1988) Myotonic dystrophy and hyperparathyroidism: association with neurofibromatosis and multiple endocrine adenomatosis type 2A. J Neurol Neurosurg Psychiatry 51:1578–1580
Reimund JM, Duclos B, Chamouard P, Warter JM, Weill JP, Baumann R (1992) Intestinal carcinoid tumor and myotonic dystrophy. A new association? Dig Dis Sci 37:1922–1925
Mudge BJ, Taylor PB, Vanderspek AF (1980) Perioperative hazards in myotonic dystrophy. Anaesthesia 35:492–495
Montella L, Caraglia M, Addeo R et al (2005) Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease). Ann Hematol 84:192–193
Molina MJ, Lara JI, Riobo P et al (1996) Primary hyperthyroidism and associated hyperparathyroidism in a patient with myotonic dystrophy: Steinert with hyperthyroidism and hyperparathyroidism. Am J Med Sci 311:296–298
Mascalchi M, Padovani R, Taiuti R, Quilici N (1998) Syringomyelia in myotonic dystrophy due to spinal hemangioblastoma. Surg Neurol 50:446–448
Kuroiwa Y, Yamada A, Ikebe K, Kosaka K, Sugita H, Murakami T (1981) Myotonic dystrophy and thymoma: a necropsy case report. J Neurol Neurosurg Psychiatry 44:173–175
Kudva GC, Maliekel K, Kim HJ et al (2002) Thymoma and myotonic dystrophy: successful treatment with chemotherapy and radiation: case report and review of the literature. Chest 121:2061–2063
Kinoshita M, Osanai R, Kikkawa M et al (2002) A patient with myotonic dystrophy type 1 (DM 1) accompanied by laryngeal and renal cell carcinomas had a small CTG triplet repeat expansion but no somatic instability in normal tissues. Intern Med 41:312–318
Kerbrat P, Toussaint C, Ben Hassel M, Guerin D (1987) Association of Steinert’s disease and testicular cancer. Presse Med 16:1434
Johannesson G, Henriksson KG, Odkvist L (1978) Coincidence of dystrophia myotonica and pleomorphic adenoma of the parotid gland. Acta Neurol Scand 57:275–278
Itin PH, Laeng RH (2001) Multiple pigmented basalioma of the scalp in a patient with Curschmann-Steinert myotonia dystrophica. Confirmation of a rare symptom constellation. Hautarzt 52:244–246
Hirai T, Yamanaka A, Fujimoto T, Takahashi A, Takayama Y, Yamanaka K (2001) Multiple thymoma with myotonic dystrophy. Jpn J Thorac Cardiovasc Surg 49:457–460
Harada S, Matsumoto T, Ikeda K, Fukumoto S, Ihara Y, Ogata E (1987) Association of primary hyperparathyroidism with myotonic dystrophy in two patients. Arch Intern Med 147:777–778
Goto IK, Ichimaru K, Maruyama T et al (1969) An autopsy case of myotonic dystrophy with familial diabetes mellitus, and mixed tumor of the parotid gland and a thymoma. Fukuoka Acta Med 60:126–133
Garcia Delgado E, Ruiz Galiana J (1988) Association of primary hyperparathyroidism with myotonic dystrophy in two patients. Arch Intern Med 148:237–241
Fraumeni JF Jr, Chabner BA, Li FP, Carbone PP (1969) Myotonic dystrophy and leukemia. JAMA 208:696
Caughey JE (1958) Hypogonadism and pituitary tumours; report of a case of dystrophia myotonica with hypogonadism and acromegaly. N Z Med J 57:482–486
Carlin L, Biller J (1981) Myotonic dystrophy and thymoma. J Neurol Neurosurg Psychiatry 44:852–853
Canovas A, Rodriguez Illera E, Arizcun A, Riva C, Diego J (1981) Myotonic dystrophy and thymoma associated with myasthenic behavior on electromyography. Rev Clin Esp 160:405–407
Bell E, Lorimer AR, Hinnie J (1994) Association between myotonic dystrophy and primary hyperparathyroidism. J Int Med Res 22:296–298
Banna M, Bradley WG, Pearce GW (1973) Massive pituitary adenoma in a patient with dystrophia myotonica. J Neurol Sci 20:1–6
Azurdia RM, Verbov JL (1999) Myotonic dystrophy and basal cell carcinoma—a true association? Br J Dermatol 141:941–942
Ando T, Goto R, Ohnishi H, Ishida M, Obara H (2004) Anesthetic management for a patient of myotonic dystrophy with pheochromocytoma. Masui 53:1290–1292
Ichikawa K, Crosley CJ, Culebras A, Weitkamp L (1981) Coincidence of neurofibromatosis and myotonic dystrophy in a kindred. J Med Genet 18:134–138
Pruzanski W, Adler H (1966) Myotonic dystrophy, acute intermittent porphyria and neurofibromatosis in one patient. Acta Genet Stat Med 16:103–112
Wong LJ, Ashizawa T, Monckton DG, Caskey CT, Richards CS (1995) Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet 56:114–122
Ansved T, Edstrom L, Grandell U, Hedberg B, Anvret M (1997) Variation of CTG-repeat number of the DMPK gene in muscle tissue. Neuromuscul Disord 7:152–155
Day JW, Ricker K, Jacobsen JF et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664
Nag DK (2003) Trinucleotide repeat expansions: timing is everything. Trends Mol Med 9:455–457
Lenzmeier BA, Freudenreich CH (2003) Trinucleotide repeat instability: a hairpin curve at the crossroads of replication, recombination, and repair. Cytogenet Genome Res 100:7–24
Cleary JD, Pearson CE (2003) The contribution of cis-elements to disease-associated repeat instability: clinical and experimental evidence. Cytogenet Genome Res 100:25–55
Reddy S, Smith DB, Rich MM et al (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 13:325–335
Jansen G, Groenen PJ, Bachner D et al (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 13:316–324
Machuca-Tzili L, Brook D, Hilton-Jones D (2005) Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 32:1–18
Kanadia RN, Johnstone KA, Mankodi A et al (2003) A muscleblind knockout model for myotonic dystrophy. Science 302:1978–1980
Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA (2004) Muscleblind proteins regulate alternative splicing. EMBO J 23:3103–3112
Ho TH, Bundman D, Armstrong DL, Cooper TA (2005) Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14:1539–1547
Lazar AJ, Calonje E, Grayson W et al (2005) Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 32:148–157
Kajino Y, Yamaguchi A, Hashimoto N, Matsuura A, Sato N, Kikuchi K (2001) Beta-catenin gene mutation in human hair follicle-related tumors. Pathol Int 51:543–548
Chan EF, Gat U, McNiff JM, Fuchs E (1999) A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 21:410–413
Gat U, DasGupta R, Degenstein L, Fuchs E (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95:605–614
Zhao X, Ren W, Yang W et al (2006) Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. Int J Cancer 118:643–648
El-Bahrawy M, El-Masry N, Alison M, Poulsom R, Fallowfield M (2003) Expression of beta-catenin in basal cell carcinoma. Br J Dermatol 148:964–970
Saldanha G, Ghura V, Potter L, Fletcher A (2004) Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 151:157–164
Reifenberger J, Knobbe CB, Wolter M et al (2002) Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100:549–556
Polakis P (2000) Wnt signaling and cancer. Genes Dev 14:1837–1851
Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600
Burt RW (2000) Colon cancer screening. Gastroenterology 119:837–853
Miller RW, Rubinstein JH (1995) Tumors in Rubinstein-Taybi syndrome. Am J Med Genet 56:112–115
Taine L, Goizet C, Wen ZQ et al (1998) Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome. Am J Med Genet 78:267–270
Roelfsema JH, White SJ, Ariyurek Y et al (2005) Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76:572–580
Bartsch O, Schmidt S, Richter M et al (2005) DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 117:485–493
Bartsch O, Locher K, Meinecke P et al (2002) Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet 39:496–501
Polakis P (2002) Casein kinase 1: a Wnt’er of disconnect. Curr Biol 12:R499–R501
Behrens J (2005) The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans 33:672–675
Iwao K, Nakamori S, Kameyama M et al (1998) Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58:1021–1026
Takemaru KI, Moon RT (2000) The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. J Cell Biol 149:249–254
Sun Y, Kolligs FT, Hottiger MO, Mosavin R, Fearon ER, Nabel GJ (2000) Regulation of beta -catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci USA 97:12613–12618
Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y (2004) Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol 24:10689–10702
Iyer NG, Ozdag H, Caldas C (2004) p300/CBP and cancer. Oncogene 23:4225–4231
Iakova P, Wang GL, Timchenko L et al (2004) Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J 23:406–417
Mukai K, Sato Y, Hirohashi S, Shimosato Y (1990) Expression of ras p21 protein by thymoma. Virchows Arch B Cell Pathol Incl Mol Pathol 59:11–16
Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I (2004) Beta-catenin simultaneously induces activation of the p53–p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 164:1739–1749
Kamei J, Toyofuku T, Hori M (2003) Negative regulation of p21 by beta-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem Biophys Res Commun 312:380–387
Gartel AL, Radhakrishnan SK (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65:3980–3985
Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ (1995) The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9:534–546
Acknowledgments
These observations are offered in memory of Dr. Robert W. Miller, Scientist Emeritus at the National Cancer Institute, who was a pioneer in leveraging alert clinical observations into paradigm-altering etiologic insights. He remains a role model and an inspiration to all those fortunate enough to have known him. Funding: This work was supported through funding provided by (1) Intramural Research Program of the National Cancer Institute (2) The National Registry of DM and FSHD Patients and Family Members is supported through the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Neurological Disorders and Stroke, #NO1-AR-5-2274 (3) University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (NIH/NS48843).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mueller, C.M., Hilbert, J.E., Martens, W. et al. Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control 20, 2009–2020 (2009). https://doi.org/10.1007/s10552-009-9395-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-009-9395-y